Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

PBD Biotech invited to speak at Fiji Bovine TB Eradication Forum

Date: 27-28 November 2019

Dr Ben Swift, co-founder of PBD Biotech, has been invited by Fiji’s Ministry of Agriculture to speak at its 2nd Bovine Brucellosis and Tuberculosis Eradication Campaign (BTEC) Forum on 27 and 28 November 2019.
Fiji

The Ministry of Agriculture of the Republic Islands of Fiji comments that it has recently become aware of the benefits of Actiphage; PBD Biotech’s rapid diagnostic for Bovine Tuberculosis (bTB) and Tuberculosis in humans.

Recognising the current gaps in the technology for detecting these diseases, the Ministry has invited Ben to come to Fiji and discuss the Actiphage test, which offers diagnosis from a single blood or milk sample.

The Brucellosis and Tuberculosis Eradication and Control programme commenced in Fiji during the 1980s and has since been sustained by government funding and industry cooperation.

A retrospective review by the University of Sydney, conducted with support from the Government of Fiji, found bTB to be well established in many dairy cattle farms across the country. To address this, a new stakeholder forum was established in 2017 and a new BTEC strategy formulated and endorsed.

Actiphage offers an improvement over the existing bTB skin test as it can detect viable mycobacteria, the pathogen that causes the disease. By detecting bTB at an early stage, before the animal becomes infectious, it provides an accurate diagnosis and an opportunity to manage the disease.

More information about using Actiphage to tackle bTB is available on our Bovine Tuberculosis page.

Share:
  • Events, International
  • event, international

Related posts

Loading...
Tom Kellner

PBD Biotech expands its North American operations

January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as Director of Operations in North America, to advise on regulatory affairs and provide technical and customer support.
Tom Kellner

PBD Biotech expands its North American operations

January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as...
Dr Cath Rees, PBD Biotech Chief Scientific Officer

18 May 2021

Rebuilding Thriving Local Economies

May 5, 2021
Businesses across the country have seen for themselves the impact of pandemic – but this has been the living nightmare for some dairy farmers for years. Dr Cath Rees, Chief Scientific Officer, PBD Biotech, developers of an accurate blood and...
Dr Cath Rees, PBD Biotech Chief Scientific Officer

18 May 2021

Rebuilding Thriving Local Economies

May 5, 2021
Businesses across the country have seen for themselves the impact of pandemic – but this has been the living nightmare...
Luis Martin

Actiphage diagnostic for Johne’s Disease gains funding from Canadian Gov

June 9, 2020
Johne’s disease, a wasting condition of cattle, costs the Canadian dairy industry an estimated $90 million a year through loss of production. Now, advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP)...
Luis Martin

Actiphage diagnostic for Johne’s Disease gains funding from Canadian Gov

June 9, 2020
Johne’s disease, a wasting condition of cattle, costs the Canadian dairy industry an estimated $90 million a year through loss...
Missouri

Bovine TB test developers selected for USA agri-food delegation

February 24, 2020
PBD Biotech, developers of a rapid new test for bovine TB, is one of seven UK agri-tech companies to have been selected to join the first Missouri Agri-Tech Connect Programme this week (23 – 27 February 2020).
Missouri

Bovine TB test developers selected for USA agri-food delegation

February 24, 2020
PBD Biotech, developers of a rapid new test for bovine TB, is one of seven UK agri-tech companies to have...
1 2 3 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More